Attachment B: 60-Day FRN

23975

Federal Register / Vol. 85, No. 84 / Thursday, April 30, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request Information
Collection Request Title: Teaching
Health Centers Graduate Medical
Education Program Cost Evaluation,
OMB No. 0906—XXXX—New
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:

SUMMARY: In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects of the Paperwork Reduction Act
of 1995, HRSA announces plans to
submit an Information Collection
Request (ICR), described below, to the
Office of Management and Budget
(OMB). Prior to submitting the ICR to
OMB, HRSA seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on this ICR should be
received no later than June 29, 2020.
ADDRESSES: Submit your comments to
paperwork@hrsa.gov.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call Lisa Wright-Solomon, the HRSA
Information Collection Clearance Officer
at (301) 443–1984.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
information request collection title for
reference.
Information Collection Request Title:
Teaching Health Centers Graduate
Medical Education Program Cost
Evaluation, OMB No. 0906–XXXX—
New.
Abstract: The Teaching Health Center
Graduate Medical Education (THCGME)

program, authorized by Section 340H of
the Public Health Service Act, was
established by Section 5508 of Public
Law (Pub. L.) 111–148. The Bipartisan
Budget Act of 2018 (Pub. L. 115–123)
provided continued funding for the
THCGME program for fiscal years 2018
and 2019 and the Coronavirus Aid,
Relief, and Economic Security Act
extends funding for Fiscal Year (FY)
2020 for the first two months of FY 2021
(until November 30, 2020).
Need and Proposed Use of the
Information: The THCGME program
awards payment for both direct and
indirect expenses to support training for
primary care residents in communitybased ambulatory patient care settings.
Direct medical expense payments are
designed to compensate eligible
teaching health centers (THC) for those
expenses directly associated with
sponsoring approved graduate medical
residency training programs, while
indirect medical expense payments are
intended to compensate for the
additional costs of training residents in
such programs. The primary goals of
this program are to increase the
production of primary care providers
who are better prepared to practice in
community settings, particularly with
underserved populations, and improve
the geographic distribution of primary
care providers.
The statute requires the Secretary of
HHS (the Secretary) to determine an
appropriate THCGME program payment
for indirect medical expenses (IME) as
well as to update, as deemed
appropriate, the per resident amount
used to determine the Program’s
payment for direct medical expenses
(DME). To inform these determinations
and to increase understanding of this
model of residency training, the George
Washington University, under contract
with HRSA, is conducting an evaluation
of the costs associated with training
residents in the THC model. George
Washington University has developed a
standardized THC Costing Instrument to
gather data from all THCGME programs
which they will use to gather costing

information related to both DME and
IME. The information gathered in the
THC Costing Instrument includes, but is
not limited to, resident and faculty fulltime equivalents salaries and benefits,
residency administration costs,
educational costs, residency clinical
operations and administrative costs,
patient visits and clinical revenue
generated by medical residents,
financial reports, as well as general
program information to understand the
characteristics of the THCGME program
and sponsoring institutions that are
involved in residency training.
HRSA is collecting costing
information related to both DME and
IME in an effort to establish a THC’s
total cost of running a residency
program, to assist the Secretary in
determining an appropriate update to
the per resident amount used to
calculate the payment for DME and an
appropriate IME payment. The
described data collection activities will
serve to inform these statutory
requirements for the Secretary in a
uniform and consistent manner.
Likely Respondents: The likely
responders to the THC Costing
Instrument are THCGME program award
recipients.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

jbell on DSKJLSW7X2PROD with NOTICES

Form name

Number of
responses per
respondent

Total
responses

Average
burden per
response
(in hours)

Total burden
hours

Teaching Health Center Costing Instrument .......................

56

1

56

10

560

Total ..............................................................................

56

........................

56

........................

560

HRSA specifically requests comments
on (1) The necessity and utility of the

VerDate Sep<11>2014

18:56 Apr 29, 2020

Jkt 250001

proposed information collection for the
proper performance of the agency’s

PO 00000

Frm 00034

Fmt 4703

Sfmt 4703

functions, (2) the accuracy of the
estimated burden, (3) ways to enhance

E:\FR\FM\30APN1.SGM

30APN1

23976

Federal Register / Vol. 85, No. 84 / Thursday, April 30, 2020 / Notices

the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020–09172 Filed 4–29–20; 8:45 am]
BILLING CODE 4165–15–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Review, National Center for Advancing
Translational Sciences, 6701 Democracy
Blvd., Rm. 1078, Bethesda, MD 20892, 301–
594–7319, khanr2@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: April 24, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.

National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meetings

[FR Doc. 2020–09116 Filed 4–29–20; 8:45 am]
BILLING CODE 4140–01–P

jbell on DSKJLSW7X2PROD with NOTICES

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; SBIR Phase II, Topic 17.
Date: May 18, 2020.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Rahat (Rani) Khan, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, 6701 Democracy
Blvd., Rm. 1078, Bethesda, MD 20892, 301–
594–7319, khanr2@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; SBIR Phase II, Topic 18.
Date: May 18, 2020.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Rahat (Rani) Khan, Ph.D.,
Scientific Review Officer, Office of Scientific

VerDate Sep<11>2014

18:56 Apr 29, 2020

Jkt 250001

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Psychosocial Development, Risk and
Prevention Study Section.
Date: June 4–5, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Anna L. Riley, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
MSC 7759, Bethesda, MD 20892, 301–
4352889, rileyann@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Neurobiology of
Learning and Memory Study Section.
Date: June 4–5, 2020.
Time: 8:00 a.m. to 6:00 p.m.

PO 00000

Frm 00035

Fmt 4703

Sfmt 9990

Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Alexei Kondratyev, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200,
MSC 7846, Bethesda, MD 20892, 301–435–
1785, kondratyevad@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group; Molecular
and Cellular Endocrinology Study Section.
Date: June 4–5, 2020.
Time: 9:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Liliana Norma BertiMattera, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Rm. 4215, Bethesda, MD 20892, liliana.bertimattera@nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Virology—B Study Section.
Date: June 4–5, 2020.
Time: 9:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Neerja Kaushik-Basu,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198,
MSC 7808, Bethesda, MD 20892, (301)435–
1742, kaushikbasun@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Neurotoxicology
and Alcohol Study Section.
Date: June 4–5, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Sepandarmaz Aschrafi,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040D,
Bethesda, MD 20892, (301) 451.4251,
Armaz.aschrafi@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 27, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–09195 Filed 4–29–20; 8:45 am]
BILLING CODE 4140–01–P

E:\FR\FM\30APN1.SGM

30APN1